Shares of BioNTech advanced significantly on Friday following an upgrade from Goldman Sachs. The US investment bank now views the...
Ciena Corporation's stock is trading at an all-time high, fueled by investor enthusiasm over its potential role in the artificial...
Intel's stock has transformed from a struggling entity into a compelling momentum play, having more than doubled in value over...
Marvell Technology finds itself navigating a complex landscape of strategic ambition and internal skepticism. The semiconductor firm’s stock has recently...
At CES 2026, Intel delivered a pivotal message to the market. The semiconductor giant announced the on-schedule—and according to management,...
Investors in Mainz-based biotechnology firm BioNTech are navigating a complex landscape of strategic progress and fresh legal uncertainty. The company...
A definitive chapter has closed for investors in CureVac. The German biotech firm's standalone history as a publicly traded company...
The financial world’s attention is fixed on Las Vegas as the technology sector converges for CES 2026. In the hours...
The new trading year has begun on a positive note for CureVac, with its shares posting significant gains. This upward...
Despite a challenging year for its share price, BioNTech concludes 2025 in a stronger strategic and financial position than market...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com